Date Title Description PDF
22 Jun 2021 On significant placements in financial instruments Hereby inform of the completion of the private placement package. The amount of the Placement amounted to a total of 87.88 million euros, being the unit selling price of 52.25 euros per share. Download
29 Apr 2021 On business and financial situation The Company informs about the increase of its fill-finish capacity for the manufacture of Moderna’s COVID-19 vaccine outside the United States.     Download
12 Apr 2021 On business and financial situation The Company releases the press release related to its participation in the manufacture of the active substance of Moderna’s COVID-19 vaccine. Download
02 Mar 2021 On business and financial situation The Company releases an update of the regulatory processes of its long-acting injectable antipsychotic, Doria®, both in Europe and the United States  Download
02 Mar 2021 On business and financial situation The Company releases a presentation related to an update of the regulatory processes of its long-acting injectable antipsychotic, Doria®, both in Europe and the United States  Download

Pages

Date Title Description PDF
29 Sep 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 22 September and 28 September 2023 Download
22 Sep 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 15 September and 21 September 2023 Download
15 Sep 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 8 September and 14 September 2023 Download
08 Sep 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 1 September and 7 September 2023 Download
01 Sep 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 25 August and 31 August 2023 Download

Pages

Date Title Description PDF
08 Nov 2016 Información sobre resultados ROVI releases the presentation related to the nine-month period ended 30 September 2016 results Download
08 Nov 2016 Información sobre resultados (2) ROVI releases the press release related to the nine-month period ended 30 September 2016 results Download
08 Nov 2016 Otros sobre Gobierno Corporativo The Company informs about the agreement of the Board of Directors with regards to the appointment of the Accounts Auditor Download
04 Oct 2016 Contratos de liquidez y contrapartida Liquidity contract: transactions conducted in the third quarter of 2016 Download
01 Aug 2016 Acuerdos estratégicos con terceros ROVI announces the marketing agreement of Mysimba in Spain Download

Pages